Clinical Policy: Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES)
Defines medical necessity criteria for neuromuscular electrical stimulation (NMES), functional electrical stimulation (FES), and peroneal nerve stimulators for members/enrollees under Centene-affiliated health plans, including eligible indications, contraindications, device-specific coverage, and HCPCS coding guidance.
Annual review. Updated language in Criteria I.A. for clarity; coding and descriptions reviewed; references updated.
Removed certain contraindications under ILF in 06/24 annual review; background updated with no impact on criteria.
Combined criteria applicable to lower extremity units into section II.G and added contraindications to Section F in prior annual reviews.
Added section III and IV criteria specifying peroneal nerve stimulators medically necessary for incomplete SCI and not proven for other indications.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.